未找到相关数据
Longer-term follow up of a phase I study of ponatinib in patients (pts) with Philadelphia chromosome-positive (Ph plus ) leukemias.
被引：7
作者：
Talpaz, Moshe
Cortes, Jorge E.
Kantarjian, Hagop M.
Shah, Neil P.
Bixby, Dale L.
Flinn, Ian
O'Hare, Thomas
Hu, Simin
Rivera, Victor M.
Clackson, Tim
Turner, Christopher D.
Haluska, Frank G.
Drucker, Brian J.
Deininger, Michael W. N.
Mauro, Michael J.
机构：
[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Sarah Cannon Res Inst, Nashville, TN USA
[5] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[6] ARIAD Pharmaceut Inc, Cambridge, MA USA
[7] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.7078
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7078
引用
收藏
页数：1
相关论文